Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Westphal

Showing results (171-180 of 309) with videos related to

Pageof 31
Sort By:
Cancer Immunology, Immunotherapy : CII|October 3, 2009
Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma modelChristian Ginzkey, Sven O Eicker, Matthias Marget, et al.
Neuro-Oncology|May 5, 2022
DNA methylation subclass receptor tyrosine kinase II (RTK II) is predictive for seizure development in glioblastoma patientsFranz L Ricklefs, Richard Drexler, Kathrin Wollmann, et al.
Scientific Reports|March 18, 2020
Initial pupil status is a strong predictor for in-hospital mortality after aneurysmal subarachnoid hemorrhageMarius M Mader, Andras Piffko, Nora F Dengler, et al.
Clinical & Translational Immunology|February 2, 2024
SARS-CoV-2-associated T-cell infiltration in the central nervous systemMalte Mohme, Christoph Schultheiß, Andras Piffko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutationsChristian Hartmann, Bettina Hentschel, Matthias Simon, et al.
Plos One|October 7, 2015
Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating CellsFabian Wolpert, Caroline Happold, Guido Reifenberger, et al.
Acta Neuropathologica Communications|August 22, 2018
Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastomaMichael W Ronellenfitsch, Pia S Zeiner, Michel Mittelbronn, et al.
The American Journal of Pathology|May 14, 2013
Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastasesIna Hohensee, Katrin Lamszus, Sabine Riethdorf, et al.
Oncotarget|November 7, 2019
Preclinical analysis of human mesenchymal stem cells: tumor tropism and therapeutic efficiency of local HSV-TK suicide gene therapy in glioblastomaLasse Dührsen, Sophie Hartfuß, Daniela Hirsch, et al.
Glia|February 5, 2011
A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic targetAlexander Schulte, Hauke S Günther, Heidi S Phillips, et al.
Pageof 31

Showing results (171-180 of 309) with videos related to

Sort By:
Pageof 31
Cancer Immunology, Immunotherapy : CII|October 3, 2009
Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma modelChristian Ginzkey, Sven O Eicker, Matthias Marget, et al.
Neuro-Oncology|May 5, 2022
DNA methylation subclass receptor tyrosine kinase II (RTK II) is predictive for seizure development in glioblastoma patientsFranz L Ricklefs, Richard Drexler, Kathrin Wollmann, et al.
Scientific Reports|March 18, 2020
Initial pupil status is a strong predictor for in-hospital mortality after aneurysmal subarachnoid hemorrhageMarius M Mader, Andras Piffko, Nora F Dengler, et al.
Clinical & Translational Immunology|February 2, 2024
SARS-CoV-2-associated T-cell infiltration in the central nervous systemMalte Mohme, Christoph Schultheiß, Andras Piffko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutationsChristian Hartmann, Bettina Hentschel, Matthias Simon, et al.
Plos One|October 7, 2015
Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating CellsFabian Wolpert, Caroline Happold, Guido Reifenberger, et al.
Acta Neuropathologica Communications|August 22, 2018
Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastomaMichael W Ronellenfitsch, Pia S Zeiner, Michel Mittelbronn, et al.
The American Journal of Pathology|May 14, 2013
Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastasesIna Hohensee, Katrin Lamszus, Sabine Riethdorf, et al.
Oncotarget|November 7, 2019
Preclinical analysis of human mesenchymal stem cells: tumor tropism and therapeutic efficiency of local HSV-TK suicide gene therapy in glioblastomaLasse Dührsen, Sophie Hartfuß, Daniela Hirsch, et al.
Glia|February 5, 2011
A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic targetAlexander Schulte, Hauke S Günther, Heidi S Phillips, et al.
Pageof 31